Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec;7(2):67-72.
doi: 10.5049/EBP.2009.7.2.67. Epub 2009 Dec 31.

Aldosterone Synthase Gene (CYP11B2) Polymorphism in Korean End-Stage Renal Disease Patients on Hemodialysis

Ji Eun Lee  1 , So Yon Bae, Jeong-Yup Kim, Heui Jung Pyo; Western Dialysis Physician Association (WDPA); Young Joo Kwon
Affiliations

Aldosterone Synthase Gene (CYP11B2) Polymorphism in Korean End-Stage Renal Disease Patients on Hemodialysis

Ji Eun Lee et al. Electrolyte Blood Press. 2009 Dec.

Abstract

Aldosterone synthase gene (CYP11B2) -344C/T polymorphism has been reported to be associated with serum aldosterone level, urinary aldosterone excretion, blood pressure, and left ventricular size and mass. The aim of this study was to evaluate the relation between CYP11B2 polymorphism and end-stage renal disease (ESRD) in the Korean population and the association with CYP11B2 polymorphism and cardiovascular morbidity in ESRD patients on hemodialysis. Genotyping was performed in 134 control subjects and 271 ESRD patients for CYP11B2 polymorphism using polymerase chain reaction through subsequent cleavage with restriction enzyme. Also current blood pressure, demographic, anthropometric and biochemical variables were investigated. The genotype distribution did not differ between ESRD patients and controls and there were no significant differences in blood pressure, use of antihypertensive medication, left ventricular hypertrophy and cardiovascular disease among the three genotypes in ESRD patients on hemodialysis. Our findings do not support the hypothesis that CYP11B2 polymorphism may be associated with prevalence of ESRD and suggest that CYP11B2 polymorphism may not be a genetic marker for cardiovascular morbidity in Korean ESRD patients.

Keywords: aldosterone synthase; polymorphism, genetic; renal dialysis.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
CYP11B2 polymorphism. CYP11B2, aldosterone synthase.
See this image and copyright information in PMC

References

    1. Perry HM, Jr., Miller JP, Fornoff JR, et al. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension. 1995;25:587–594. - PubMed
    1. Klag MJ, Whelton PK, Randall BL, et al. Blood pressure and end-stage renal disease in men. N Engl J Med. 1996;334:13–18. - PubMed
    1. Hata A. Role of angiotensinogen in the genetics of essential hypertension. Life Sci. 1995;57:2385–2395. - PubMed
    1. Niu T, Chen X, Xu X. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease. Drugs. 2002;62:977–993. - PubMed
    1. Schmidt S, Beige J, Walla-Friedel M, Michel MC, Sharma AM, Ritz E. A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hyperension. J Hypertens. 1997;15:1385–1388. - PubMed

LinkOut - more resources